Clinicopathologic Changes of IgA Nephropathy in Children During Long-term (average 10.8 yrs) Follow-up.
- Author:
Chang Min MOON
1
;
Pyung Kil KIM
;
Beom Jin LIM
;
Ji Sun SONG
;
Hyeon Joo JEONG
Author Information
1. Department of Pediatrics, Kwandong University, College of Medicine, Goyang, Korea. pkkim36@yahoo.co.kr
- Publication Type:Original Article
- Keywords:
IgA nephropathy;
Children;
Haas classification;
Prognosis
- MeSH:
Angiotensin Receptor Antagonists;
Angiotensin-Converting Enzyme Inhibitors;
Biopsy;
Child;
Cyclosporine;
Follow-Up Studies;
Glomerulonephritis, IGA;
Humans;
Hypertension;
Immunoglobulin A;
Medical Records;
Prognosis
- From:Journal of the Korean Society of Pediatric Nephrology
2010;14(2):154-165
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We know little about the natural course of IgA nephropathy (IgAN) in association with histologic changes especially in children. We investigated clinicopathologic features with long-term follow-up biopsy to clarify the outcomes and prognostic indicators for childhood IgAN. METHODS: From our patients' medical records, we retrieved 20 patients with IgAN, to whom renal biopsies had been performed for the initial diagnosis and follow-up to find out any histologic changes. Initial and follow-up biopsies were classified by Haas classification. The changes of these parameters were compared with the evolution of clinical features. RESULTS: Patients were treated with angiotensin-converting enzyme inhibitors in combination with angiotensin receptor blockers (in subclass II or above) and short-term cyclosporine A(in patients showing nephrotic syndrome). Histologic improvement in 7 cases and deterioration in 3 cases were observed. At the time of last biopsy, 10 cases (50%) showed clinical remission and the others showed improved clinical features. These clinical outcomes did not correlate with initial Haas classifications. Hypertension at onset observed in 5 cases (25%) revealed significant correlation with clinical outcome (P=0.01) and last Haas classification (P=0.007). None of the cases showed progression to CRF or ESRD. CONCLUSION: During a mean follow-up of 10.8+/-3.4 years, childhood IgAN showed good clinicopathologic outcome. Hypertension at onset was only a strong predictor of clinicopathologic outcomes, but initial Haas classification cannot predict outcomes in children. Histologic change of IgAN in long term follow-up period cannot be completely predicted by clinical data and vice versa. Therefore, a renal biopsy should be considered as a part of follow-up plan.
